|
業務類別
|
Biotechnology |
|
業務概覽
|
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties. |
| 公司地址
| 1775 West Oak Commons Court, NE, Marietta, GA, USA, 30062 |
| 電話號碼
| +1 770 651-9100 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.mimedx.com |
| 員工數量
| 808 |
| Ms. Ricci S Whitlow |
Executive Vice President and Chief Operating Officer |
美元 540.00K |
30/04/2025 |
| Mr. Douglas C. Rice |
Chief Financial Officer and Chief Accounting Officer |
美元 540.00K |
25/02/2026 |
| Mr. William Frank Hulse, IV |
General Counsel and Chief Administrative Officer |
美元 546.00K |
30/04/2025 |
| Mr. Joseph H. Capper |
Director and Chief Executive Officer |
美元 750.00K |
25/02/2026 |
| Ms. Kimberly Maersk-Moller |
Chief Commercial Officer |
-- |
30/04/2025 |
|
|
| Dr. Cato T. Laurencin,M.D.,PhD |
Independent Director |
25/02/2026 |
| Mr. Martin P. Sutter |
Independent Director |
25/02/2026 |
| Dr. M. Kathleen Behrens Wilsey, PhD |
Chairman of the Board |
25/02/2026 |
| Mr. William A. Hawkins, III |
Independent Director |
25/02/2026 |
| Mr. James L. Bierman |
Independent Director |
25/02/2026 |
| Mr. K. Todd Newton |
Independent Director |
25/02/2026 |
| Ms. Tiffany P. Olson, M.B.A. |
Independent Director |
25/02/2026 |
| Ms. Dorothy E. Puhy |
Independent Director |
25/02/2026 |
| Mr. Joseph H. Capper |
Director and Chief Executive Officer |
25/02/2026 |
|
|
|
|
